US · BNBX
BNB Plus Corp.
- Sector
- Healthcare · Biotechnology
- Headquarters
- Stony Brook, NY 11790
- Website
- bnbx.io
Price · as of 2026-07-02
$0.36
Market cap 529.98K
Price history
Valuation history
Annual price overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | |||||
| 2023 | |||||
| 2024 | |||||
| 2025 | $3.00 |
USD millions
Line items
USD millions
Line items
USD millions
Line items
Peer comparison
Same-industry comparables, ranked by market cap.
Scroll horizontally for additional metrics. Ticker column stays fixed.
| Basic Info | Model Valuation | Core Valuation | Growth | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | Sales Growth |
| BNBX | BNB Plus Corp. | $0.39 | 529.98K | — | — | — | — | -0.10 | 0.67 | 0.73 | -0.01 | — |
| BGMS | Bio Green Med Solution, I… | $1.05 | 2.29M | — | — | — | — | — | — | — | — | — |
| BNGO | Bionano Genomics, Inc. | $1.25 | 4.1M | — | — | — | — | — | — | — | — | — |
| ISPC | iSpecimen Inc. | $3.32 | 461.02K | — | — | — | +185,560% | — | — | — | — | — |
| KZIA | Kazia Therapeutics Limite… | $12.67 | 20.52M | +37% | -76% | — | +9,097% | -0.63 | -1.56 | 309.03 | -0.68 | -9818.00% |
| NAOV | NanoVibronix, Inc. | $1.90 | 1.51M | +74,476% | +729% | — | — | -2.87 | 16.95 | 4.15 | -2.71 | 1205.00% |
| NDRA | ENDRA Life Sciences Inc. | $5.52 | 4.15M | — | — | — | — | -0.34 | 1.54 | — | -0.12 | — |
| RDHL | RedHill Biopharma Ltd. | $1.00 | 3.14M | — | — | -33% | +1,042% | — | — | — | — | — |
| VERO | Venus Concept Inc. | $0.31 | 578.19K | +37,205% | +289% | — | +132,414% | -0.05 | 0.91 | 0.03 | -1.14 | -1509.00% |
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $0.36) − 1 = — (DCF, example).